Health and Healthcare

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

143 Articles

Chris Lange | Oct 1, 2015 at 8:35 AM EDT

Sarepta Makes Headway With Phase 2 Program

Sarepta Therapeutics announced additional clinical efficacy and safety data from its Phase 2b program of eteplirsen in patients with Duchenne…

Jon C. Ogg | Aug 7, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom, Disney and Many More

Friday's top analyst upgrades, downgrades and initiations include BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom and Disney.

Jon C. Ogg | Jun 30, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apollo, Petrobras, Shopify, Fitbit, Sarepta, Lowe’s and More

Tuesday's top analyst upgrades, downgrades and initiations include Apollo Education, Petrobras, Shopify, Fitbit, Sarepta Therapeutics and Lowe's.

Chris Lange | Jun 29, 2015 at 3:20 PM EDT

Sarepta Takes Its Foot off the Gas

Sarepta Therapeutics announces the completion of the rolling submission of a New Drug Application to the FDA for eteplirsen.

Chris Lange | May 20, 2015 at 11:10 AM EDT

How Sarepta Short Interest Is Adding to Its Gains

Analysts are beginning to flock to Sarepta after the company made news surrounding a meeting with the FDA, not to…

Jon C. Ogg | May 20, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Achillion, CSC, Keurig, Sarepta, Splunk and More

Wednesday's top analyst upgrades, downgrades and initiations include Achillion Pharmaceuticals, Computer Sciences, Keurig Green Mountain, Sarepta Therapeutics and Splunk.

Jon C. Ogg | May 6, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Borderfree, Genworth, Groupon, Nationstar, SolarCity, Zulily and More

Wednesday's top analyst upgrades, downgrades and initiations include Borderfree, Genworth Financial, Groupon, Nationstar Mortgage, SolarCity and Zulily.

Chris Lange | Feb 17, 2015 at 3:01 PM EST

Why 1 Analyst Sees Over 50% Upside in Sarepta

Sarepta Therapeutics received a favorable rating from Merrill Lynch, and as a result the stock soared in Tuesday's trading session.

Jon C. Ogg | Feb 5, 2015 at 8:35 AM EST

Top Analyst Upgrades and Downgrades: Ally, Apple, ADP, Brocade, Level 3, Tyco and More

Thursday's top analyst upgrades, downgrades and initiations include Ally FInancial, Apple, Automatic Data Processing, Brocade Communications, Level 3 Communications and…

Lee Jackson | Jan 21, 2015 at 8:15 AM EST

Top Analyst Upgrades and Downgrades: Exxon, Lowe’s, Paycom, Under Armour, Wal-Mart, Verizon and More

Wednesday's leading analyst upgrades, downgrades and initiations from top research calls from around Wall Street include Exxon, Lowe's, Paycom Software,…

Chris Lange | Nov 24, 2014 at 9:15 AM EST

Big News for Ebola Stocks

Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but…

Chris Lange | Nov 12, 2014 at 2:10 PM EST

Ebola Stock Short Interest Surprise

Some Ebola-related stocks had been heavily shorted as they were considered by many investors as the next would-be stock bubble…

Jon C. Ogg | Oct 28, 2014 at 7:55 AM EDT

Top Analyst Upgrades and Downgrades: GoPro, Twitter, Sarepta, Yodlee and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, October 28, 2014.

Chris Lange | Oct 27, 2014 at 11:10 AM EDT

Sarepta Faces Major Hurdle, and Not From Ebola

Sarepta Therapeutics shares took a big hit on Monday morning as disappointing news started its week out on the wrong…

Jon C. Ogg | Oct 23, 2014 at 3:30 PM EDT

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

ThinkstockJust when you thought the Ebola virus outbreak risk was dwindling down… Fresh headlines from Dow Jones and the New…

1 … 6 7 8 9 10

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

Sarepta Makes Headway With Phase 2 Program

Top Analyst Upgrades and Downgrades: BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom, Disney and Many More

Top Analyst Upgrades and Downgrades: Apollo, Petrobras, Shopify, Fitbit, Sarepta, Lowe’s and More

Sarepta Takes Its Foot off the Gas

How Sarepta Short Interest Is Adding to Its Gains

Top Analyst Upgrades and Downgrades: Achillion, CSC, Keurig, Sarepta, Splunk and More

Top Analyst Upgrades and Downgrades: Borderfree, Genworth, Groupon, Nationstar, SolarCity, Zulily and More

Why 1 Analyst Sees Over 50% Upside in Sarepta

Top Analyst Upgrades and Downgrades: Ally, Apple, ADP, Brocade, Level 3, Tyco and More

Top Analyst Upgrades and Downgrades: Exxon, Lowe’s, Paycom, Under Armour, Wal-Mart, Verizon and More

Big News for Ebola Stocks

Ebola Stock Short Interest Surprise

Top Analyst Upgrades and Downgrades: GoPro, Twitter, Sarepta, Yodlee and More

Sarepta Faces Major Hurdle, and Not From Ebola

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Sarepta Therapeutics : SRPT

All Sarepta Therapeutics Articles

Sarepta Makes Headway With Phase 2 Program

Top Analyst Upgrades and Downgrades: BankUnited, Barrick Gold, ConocoPhillips, Michael Kors, Mylan, Viacom, Disney and Many More

Top Analyst Upgrades and Downgrades: Apollo, Petrobras, Shopify, Fitbit, Sarepta, Lowe’s and More

Sarepta Takes Its Foot off the Gas

How Sarepta Short Interest Is Adding to Its Gains

Top Analyst Upgrades and Downgrades: Achillion, CSC, Keurig, Sarepta, Splunk and More

Top Analyst Upgrades and Downgrades: Borderfree, Genworth, Groupon, Nationstar, SolarCity, Zulily and More

Why 1 Analyst Sees Over 50% Upside in Sarepta

Top Analyst Upgrades and Downgrades: Ally, Apple, ADP, Brocade, Level 3, Tyco and More

Top Analyst Upgrades and Downgrades: Exxon, Lowe’s, Paycom, Under Armour, Wal-Mart, Verizon and More

Big News for Ebola Stocks

Ebola Stock Short Interest Surprise

Top Analyst Upgrades and Downgrades: GoPro, Twitter, Sarepta, Yodlee and More

Sarepta Faces Major Hurdle, and Not From Ebola

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

The $1,000 Hidden Tax on Every $10,000 Invested in This NVIDIA ETF

Everyone’s Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead

Featured Reads

Why High-Earning Pilots Should Delay 401(k) Roth Conversions Until After Mandatory Retirement at 65

Everyone's Chasing The Villages. Smart Retirees Are Quietly Buying Here Instead